Legend Biotech - Stock Price History | LEGN

Historical daily share price chart and data for Legend Biotech since 2021 adjusted for splits. The latest closing stock price for Legend Biotech as of September 27, 2021 is 46.99.
  • The all-time high Legend Biotech stock closing price was 49.05 on July 22, 2021.
  • The Legend Biotech 52-week high stock price is 49.49, which is 5.3% above the current share price.
  • The Legend Biotech 52-week low stock price is 23.41, which is 50.2% below the current share price.
  • The average Legend Biotech stock price for the last 52 weeks is 32.79.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Legend Biotech Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 32.1928 37.0000 42.5600 25.8000 28.1600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.800B $0.076B
Legend Biotech Corporation is a clinical-stage biopharmaceutical company. It engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's lead product consist LCAR-B38M/JNJ-4528, which are in clinical stage. Legend Biotech Corporation is based in Cayman Islands.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29